CLS Holdings PLC

Capital/Financing Update • Dec 14, 2022

National Storage Mechanism | Additional information

RNS Number : 6044J

Glantus Holdings PLC

14 December 2022

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

Glantus Holdings plc

(''Glantus'' or the ''Company'')

Repayment of Short Term Working Capital Facility

Glantus (AIM: GLAN), the provider of Accounts Payable ("AP") automation and analytics solutions, is pleased to announce that the €1.5m additional short term working capital facility, which was drawn down from its existing Beach Point debt facility, as announced by the Company on 24 October 2022, has now been fully repaid as scheduled prior to 31 December 2022.

Enquiries:

Glantus Holdings
Maurice Healy, CEO Diane Gray Smith, interim CFO ir@glantus.com	+ 353 862677800
Shore Capital
Nominated Advisor and Broker Patrick Castle / John More / Tom Knibbs	+ 44 207 408 4090
Yellow Jersey PR
Charles Goodwin Lilian Filips Annabelle Wills	+ 44 7747 788 221

About Glantus Holdings plc

Glantus Holdings (AIM: GLAN) Glantus is a global provider of accounts payable automation and analytics solutions. Glantus' mission is to harness technology to drive innovation, unlocking efficiencies in AP to maximise working capital for global enterprise organisations. The award-winning Glantus DataShark Platform connects all AP systems and suppliers on one agile platform, eliminating cost and delivering new revenue streams. We work in tandem with our partners to deliver joint enterprise digital transformation solutions. For more information see glantus.com.

Founded in 2014 and headquartered in Dublin, Glantus has offices in the United States, United Kingdom, Poland and Costa Rica, employing over 100 people.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGPGAUPUPPGRW